Woo J. Lee
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 155 publications
Association Between Remnant Cholesterol and Muscle Mass and Quality: Insights from Muscle Quality Mapping and Abdominal Computed Tomography.
Journal: Diagnostics (Basel, Switzerland)
Published: March 27, 2026
High prevalence of non-receipt of cancer-directed therapy among the oldest old persists independent of healthcare accessibility: A population-based analysis of 82,864 patients.
Journal: Cancer epidemiology
Published: March 13, 2026
Efficacy and Safety of Pregabalin and Alpha-Lipoic Acid Combination in Patients With Painful Diabetic Peripheral Neuropathy: A Randomized, Open-Label, Non-Inferiority, Phase IV Clinical Trial and Subgroup Analysis (OPTIMUM Study).
Journal: Diabetes, obesity & metabolism
Published: February 03, 2026
Defining Obesity Under the Lancet Commission Criteria: Metabolic Syndrome-Anchored Body Fat Percentage Thresholds in Korean Adults.
Journal: Diabetes, obesity & metabolism
Published: February 02, 2026
Association of Abdominal Myosteatosis and Visceral Fat Obesity with Arterial Stiffness.
Journal: Endocrinology and metabolism (Seoul, Korea)
Published: October 22, 2025
Bridging Evidence and Practice: A Consensus Statement from the Korean Diabetes Association on Diabetes Screening, Pharmacological Treatment and Severe Diabetes.
Journal: Diabetes & metabolism journal
Published: October 01, 2025
Glycemic, renal, and graft outcomes with dulaglutide versus multiple daily insulin therapy after kidney transplantation in type 2 diabetes.
Journal: Diabetes research and clinical practice
Published: August 25, 2025
Real-World Evidence of Long-Term Dulaglutide Use: Sustained Glycemic and Weight Improvements Beyond Three Years.
Journal: Clinical endocrinology
Published: August 11, 2025
2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association.
Journal: Diabetes & metabolism journal
Published: May 28, 2025
Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third-line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP-4 inhibitors: A multicentre, phase 4 randomized controlled trial.
Journal: Diabetes, obesity & metabolism
Published: May 18, 2025
Comparison of diagnostic criteria for fatty liver disease in assessing cardiac dysfunction: a cross-sectional study.
Journal: Hepatology international
Published: April 28, 2025
Role of estimated glucose disposal rate in predicting myosteatosis: Insights from abdominal CT analysis.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: March 14, 2025
Last Updated: 09/26/2026